AIDS, HIV & STDs Research Reports
Herpes Zoster (Shingles) - Pipeline Review, H2 2011
Topics: AIDS, HIV & STDs, Drug Discovery
| HIV / AIDS - Pipeline Review, H2 2011
Topics: AIDS, HIV & STDs, Drug Discovery
| Herpes Simplex Therapeutics - Pipeline Assessment and Market Forecasts to 2018
Topics: AIDS, HIV & STDs, Drug Discovery, Reproductive Health
| AIDS - Related Cancers - Pipeline Review, H2 2011
Topics: AIDS, HIV & STDs, Drug Discovery, Oncology/Hematology
| Gilead's newly approved drug Complera, the Second Triple Combination Once-a-Day Pill Intended for Untreated HIV Patients is unlikely to displace its own market-leading drug, Atripla
Topics: AIDS, HIV & STDs, Prescription Drugs
| The HIV Market Outlook to 2016
Topics: AIDS, HIV & STDs
| AIDS-Related Kaposi's Sarcoma - Pipeline Review, Q3 2011
Topics: AIDS, HIV & STDs, Oncology/Hematology
| HIV-Associated Lipodystrophy Syndrome - Pipeline Review, Q3 2011
Topics: AIDS, HIV & STDs
| AIDS Associated Dementia - Pipeline Review, Q3 2011
Topics: AIDS, HIV & STDs, Drug Discovery
| Aids - Related Lymphoma - Pipeline Review, Q3 2011
Topics: AIDS, HIV & STDs, Drug Discovery
| Epidemiology: HIV - Antiretrovirals prevail as patient population grows
Topics: AIDS, HIV & STDs
| HIV-Associated Lipodystrophy Therapeutics - Pipeline Assessment and Market Forecasts to 2017
Topics: AIDS, HIV & STDs
| AIDS-Related Opportunistic Infections - Pipeline Review, Q2 2011
Topics: AIDS, HIV & STDs, Drug Discovery
| HIV-1 Infection Global Clinical Trials Review, Q2, 2011
Topics: AIDS, HIV & STDs
| Key Companies: HIV - Companies co-operate and co-formulate to stay competitive in a tight HIV market
Topics: AIDS, HIV & STDs
| AIDS-related Kaposi's Sarcoma (ARKS) Therapeutics - Pipeline Assessment and Market Forecasts to 2017
Topics: AIDS, HIV & STDs, Research & Development
| MarketVIEW - Chlamydia trachomatis vaccines
Topics: AIDS, HIV & STDs, Research & Development, Vaccines
| AIDS-Related Kaposi's Sarcoma (ARKS) Therapeutics -Pipeline Assessment and Market Forecasts to 2017
Topics: AIDS, HIV & STDs
| Transfusion Diagnostic Testing Market: US, Europe, Japan--Emerging Opportunities And Business Expansion Strategies for Suppliers
Topics: AIDS, HIV & STDs, Hepatitis, Blood Banking & Tissue Typing, Histology & Cytology
Regions: Japan, United States, Europe
| Genital Herpes Therapeutics - Pipeline Assessment and Market Forecasts to 2017
Topics: AIDS, HIV & STDs
| Herpes Labialis (Oral Herpes) - Pipeline Review, Q2 2011
Topics: AIDS, HIV & STDs
| Chlamydia Infections - Pipeline Review, Q2 2011
Topics: AIDS, HIV & STDs, Drug Discovery
| HIV Pain - Pipeline Review, Q2 2011
Topics: AIDS, HIV & STDs, Drug Discovery
| Specialty Pharmaceutical Industry - 2011 Yearbook
Topics: AIDS, HIV & STDs, Pharmaceuticals Company Reports, Manufacturing, Packaging & Detailing, Research & Development, Prescription Drugs, Rheumatology/Arthritis
| HIV-AIDS Therapeutics - Pipeline Assessment and Market Forecasts to 2017
Topics: AIDS, HIV & STDs
| Case Study: HIV - Better differential pricing strategies are needed to ensure access to HIV drugs
Topics: AIDS, HIV & STDs
| HIV/AIDS Therapeutics - Pipeline Assessment and Market Forecasts to 2017
Topics: AIDS, HIV & STDs
| Anal Cancer - Pipeline Review, Q2 2011
Topics: AIDS, HIV & STDs, Drug Discovery, Oncology/Hematology
| Aids - Related Cancers - Pipeline Review, Q2 2011
Topics: AIDS, HIV & STDs, Oncology/Hematology
| Herpes Zoster Global Clinical Trials Review, Q1, 2011
Topics: AIDS, HIV & STDs, Clinical Trial
| Herpes Simplex Global Clinical Trials Review, Q1, 2011
Topics: AIDS, HIV & STDs, Clinical Trial
| Herpes Labialis Global Clinical Trials Review, Q1, 2011
Topics: AIDS, HIV & STDs, Clinical Trial
| Genital Herpes Global Clinical Trials Review, Q1, 2011
Topics: AIDS, HIV & STDs, Clinical Trial
| Gonorrhea Global Clinical Trials Review, Q1, 2011
Topics: AIDS, HIV & STDs, Clinical Trial
| Herpes Simplex Virus Treatment
Topics: AIDS, HIV & STDs
Regions: Global
| Genital Warts Global Clinical Trials Review, Q1, 2011
Topics: AIDS, HIV & STDs, Drug Discovery
| AIDS Associated Malignancies Clinical Trials Consortium - Developmental Therapeutics Review - Q1 2011
Topics: AIDS, HIV & STDs, Research & Development, Drug Discovery, Clinical Trial
| Lipodystrophy - Pipeline Review, Q1 2011
Topics: AIDS, HIV & STDs, Drug Discovery
| AIDS Malignancy Clinical Trials Consortium - Developmental Therapeutics Review - Q1 2011
Topics: AIDS, HIV & STDs, Clinical Trial
| R&D Trends: HIV - An active pipeline faces fierce competition in the HIV market
Topics: AIDS, HIV & STDs, Research & Development
| R&D Trends: HIV - An active pipeline faces fierce competition in the HIV market
Topics: AIDS, HIV & STDs, Research & Development
| R&D Trends: HIV - An active pipeline faces fierce competition in the HIV market
Topics: AIDS, HIV & STDs, Research & Development
| R&D Trends: HIV - An active pipeline faces fierce competition in the HIV market
Topics: AIDS, HIV & STDs, Research & Development
| R&D Trends: HIV - An active pipeline faces fierce competition in the HIV market
Topics: AIDS, HIV & STDs, Drug Discovery
| Asian Vaccine Markets: India, China, Japan, Korea, Indonesia and Rest of Asia
Topics: AIDS, HIV & STDs, Hepatitis, Regulation & Policy, Research & Development, Vaccines, Infectious Diseases, Cancer Vaccines, Pandemic Vaccines
Regions: China, India
| Chlamydia Infections Global Clinical Trials Review, Q1, 2011
Topics: AIDS, HIV & STDs, Research & Development, Drug Discovery
| AIDS HIV Therapy Area Pipeline Report
Topics: AIDS, HIV & STDs
| Herpes Simplex Virus Infection Therapy Area Pipeline Report
Topics: AIDS, HIV & STDs
| Warts Therapy Area Pipeline Report
Topics: AIDS, HIV & STDs, Drug Discovery
| Herpes zoster infections Therapy Area Pipeline Report
Topics: AIDS, HIV & STDs
|
Prev | 1 | 2 | 3 | 4 | 5 | 6 | Next
About MarketResearch.com
MarketResearch.com is an online aggregator selling over 400,000 market research reports, company profiles and country profiles from over 720 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.
|
